Great science is essential—but it’s not enough to attract investors in today’s competitive animal health landscape. Funders are looking for startups that understand the full journey from R&D to regulatory to revenue—and can execute it with clarity, confidence, and the right partners.
Whether you're pitching at the Animal Health Summit or preparing for a Series A round, here’s what investors are really looking for in animal health startups—and how to set your company apart.
1. A Product That Solves a Real Market Problem
The most investable startups are tackling problems that veterinarians, producers, or pet owners face—and doing so in a way that’s clinically useful and commercially viable.
- Clear therapeutic indication or unmet need
- Easy administration (oral, feed, topical, long-acting injectable)
- Strong safety profile for the target species
- Demonstrated demand or vet KOL interest
Investor insight: Products designed only for regulatory approval—but not market practicality—tend to stall post-approval.
2. Regulatory Path Clarity (Not Just a Plan, but Progress)
Investors expect more than an idea—they want to see that you’ve engaged with the right agency (FDA CVM or USDA CVB) and understand the steps ahead.
- INAD or USDA ‘jurisdiction evaluation complete
- Defined regulatory milestones (e.g., pre-submission meetings, stability timelines
- Early manufacturing and analytical validation underway
- Knowledge of species-specific regulatory challenges
Red flag: No regulatory consultant or advisor on your deck.
3. Scalable Manufacturing and CMC Maturity
Manufacturing matters—especially in animal health, where flavoring, dosing, excipient safety, and packaging add complexity across species.
- Early attention to commercialization manufacturing routes and product stability
- CMC documentation (even draft) started and reviewed
- Realistic scale-up plan with a CDMO identified
- Container closure, shelf-life, and labeling plans in progress
Investor insight: Lack of CMC foresight signals operational risk.
4. A Clear Commercial Model
Veterinary products often bypass traditional pharmacy distribution. Investors want to know how your product gets to market, how it's priced, and who will drive adoption.
- Defined sales channels (e.g., direct-to-vet, distributor, B2B licensing)
- Early vet engagement or pilot partnerships
- Reasonable pricing strategy for pet or livestock segments
- Global expansion potential where feasible
Tip: Partnering early with commercial advisors or BD firms shows preparedness.
5. A Team with the Right Experience (or the Right Partners)
Founders don’t have to know everything—but they need to surround themselves with people who do.
- Regulatory advisor or firm on board
- QA, manufacturing, and CMC consultants engaged
- Veterinary KOL or clinician advisor involved
- Leadership with some commercial, technical, or licensing experience
Bonus points: A known regulatory partner like DSI attached to your submission plan.
How DSI Helps Animal Health Startups Get Funded
At DSI, we help startups:
- Build investor-ready regulatory roadmaps
- Conduct CMC gap assessments and author Module 3 content
- Identify U.S.-based manufacturing partners or submission agents
- Advise on tech transfer, quality systems, and due diligence prep
- Support early discussions with CVM or USDA or product license meetings with regulators
Whether you’re gearing up for a pitch or preparing a data room, we bring technical credibility that builds investor trust.
Final Thoughts
Veterinary startups that win funding aren’t just the most innovative—they’re the most prepared. By showing investors a clear path from concept to commercialization, with regulatory and manufacturing confidence built in, you dramatically increase your chances of standing out.
Need help getting your veterinary startup investor ready?
DSI brings the regulatory, CMC, and operational insight to move you forward. Let’s connect.
